Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

Similar articles for PubMed (Select 24356466)

1.

GSK-3β inhibition attenuates LPS-induced death but aggravates radiation-induced death via down-regulation of IL-6.

Li B, Zhang C, He F, Liu W, Yang Y, Liu H, Liu X, Wang J, Zhang L, Deng B, Gao F, Cui J, Liu C, Cai J.

Cell Physiol Biochem. 2013;32(6):1720-8. doi: 10.1159/000356606. Epub 2013 Dec 13.

PMID:
24356466
2.

A new class of molecular targeted radioprotectors: GSK-3beta inhibitors.

Thotala DK, Geng L, Dickey AK, Hallahan DE, Yazlovitskaya EM.

Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):557-65. doi: 10.1016/j.ijrobp.2009.09.024.

3.

Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.

Xia YX, Lu L, Wu ZS, Pu LY, Sun BC, Wang XH.

Hepatobiliary Pancreat Dis Int. 2012 Jun;11(3):278-84.

4.
5.

Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts.

Die L, Yan P, Jun Jiang Z, Min Hua T, Cai W, Xing L.

Mol Immunol. 2012 Aug;52(1):38-49. doi: 10.1016/j.molimm.2012.04.005. Epub 2012 May 14.

PMID:
22580404
6.
7.
8.

Inhibition of glycogen synthase kinase 3β ameliorates D-GalN/LPS-induced liver injury by reducing endoplasmic reticulum stress-triggered apoptosis.

Chen L, Ren F, Zhang H, Wen T, Piao Z, Zhou L, Zheng S, Zhang J, Chen Y, Han Y, Duan Z, Ma Y.

PLoS One. 2012;7(9):e45202. doi: 10.1371/journal.pone.0045202. Epub 2012 Sep 28.

9.

Protein kinase B/Akt-dependent phosphorylation of glycogen synthase kinase-3beta in irradiated vascular endothelium.

Tan J, Geng L, Yazlovitskaya EM, Hallahan DE.

Cancer Res. 2006 Feb 15;66(4):2320-7.

10.

Neuroprotective effects of pretreatment with propofol in LPS-induced BV-2 microglia cells: role of TLR4 and GSK-3β.

Gui B, Su M, Chen J, Jin L, Wan R, Qian Y.

Inflammation. 2012 Oct;35(5):1632-40. doi: 10.1007/s10753-012-9478-x.

PMID:
22588329
11.

Selective GSK-3beta inhibitors attenuate the cisplatin-induced cytotoxicity of auditory cells.

Park HJ, Kim HJ, Bae GS, Seo SW, Kim DY, Jung WS, Kim MS, Song MY, Kim EK, Kwon KB, Hwang SY, Song HJ, Park CS, Park RK, Chong MS, Park SJ.

Hear Res. 2009 Nov;257(1-2):53-62. doi: 10.1016/j.heares.2009.08.001. Epub 2009 Aug 8.

PMID:
19666099
12.

IL-6 augmented motility of airway epithelial cell BEAS-2B via Akt/GSK-3β signaling pathway.

Wang WC, Kuo CY, Tzang BS, Chen HM, Kao SH.

J Cell Biochem. 2012 Nov;113(11):3567-75. doi: 10.1002/jcb.24235.

PMID:
22740511
13.
14.
15.

Inhibiting glycogen synthase kinase 3beta in sepsis.

Dugo L, Collin M, Allen DA, Patel NS, Bauer I, Mervaala E, Louhelainen M, Foster SJ, Yaqoob MM, Thiemermann C.

Novartis Found Symp. 2007;280:128-42; discussion 142-6, 160-4.

PMID:
17380792
16.

GSK-3β-induced ASK1 stabilization is crucial in LPS-induced endotoxin shock.

Noh KT, Park YM, Cho SG, Choi EJ.

Exp Cell Res. 2011 Jul 15;317(12):1663-8. doi: 10.1016/j.yexcr.2011.03.022. Epub 2011 Apr 16.

PMID:
21515258
18.

Inhibition of glycogen synthase kinase 3 beta attenuates neurocognitive dysfunction resulting from cranial irradiation.

Thotala DK, Hallahan DE, Yazlovitskaya EM.

Cancer Res. 2008 Jul 15;68(14):5859-68. doi: 10.1158/0008-5472.CAN-07-6327. Erratum in: Cancer Res. 2008 Oct 1;68(19):8189.

19.

Inhibition of glycogen synthase kinase-3beta is sufficient for airway smooth muscle hypertrophy.

Deng H, Dokshin GA, Lei J, Goldsmith AM, Bitar KN, Fingar DC, Hershenson MB, Bentley JK.

J Biol Chem. 2008 Apr 11;283(15):10198-207. doi: 10.1074/jbc.M800624200. Epub 2008 Feb 5.

20.

GSK-3β inhibition promotes cell death, apoptosis, and in vivo tumor growth delay in neuroblastoma Neuro-2A cell line.

Dickey A, Schleicher S, Leahy K, Hu R, Hallahan D, Thotala DK.

J Neurooncol. 2011 Aug;104(1):145-53. doi: 10.1007/s11060-010-0491-3. Epub 2010 Dec 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk